自己免疫疾患治療薬の世界市場

◆英語タイトル:Autoimmune Disease Therapeutics - Global Market Outlook (2015-2022)
◆商品コード:SMRC65017
◆発行会社(調査会社):Stratistics MRC
◆発行日:2016年3月
◆ページ数:137
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥473,100見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥598,500見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、自己免疫疾患治療薬の世界市場について調査・分析し、市場動向、市場規模、市場予測、企業動向などを含め、以下の構成でお届けいたします。

・エグゼクティブサマリー
・序文
・市場動向分析
・ファイブフォース分析(市場環境分析)
・自己免疫疾患治療薬の世界市場:販売チャネル別分析/市場規模
・自己免疫疾患治療薬の世界市場:薬品種類別分析/市場規模
・自己免疫疾患治療薬の世界市場:地域別分析/市場規模
・自己免疫疾患治療薬のアメリカ市場規模予測
・自己免疫疾患治療薬のヨーロッパ市場規模予測
・自己免疫疾患治療薬のアジア市場規模予測
・企業動向
・企業分析
【レポートの概要】

According to Stratistics MRC, the Global Autoimmune Disease Therapeutics Market is accounted for $51.2 billion in 2015 and is expected to reach $82.13 billion by 2022 growing at a CAGR of 6.9% during the forecast period. Rising healthcare expenditure in the region is one of the key factors fueling the market growth. On the other hand, insufficient funding in emerging countries and high cost involved in the treatment of the disease are hindering the market. Biologics drug acts as initial line of treatment due to therapeutic capabilities in controlling and treatment of different autoimmune complications.
North America is the largest market for autoimmune disease therapeutics due to increasing incidence of different forms of autoimmune disorders, and government initiatives in the region. Europe is expected to be the second largest market due to rising healthcare infrastructure and penetration of new technologies.

Some of the key players in the market include Johnson & Johnson Inc, Bayer Schering Pharma AG, Elan Corporation Plc, Abbott Laboratories, Genentech Inc, GlaxoSmithKline Plc, Bristol-Myers Squibb, Chugai Pharmaceutical Co. Ltd., Merck & Co. Inc, Amgen Inc, Eli Lilly and Company, F. Hoffmann-La Roche AG, Biogen Idec Inc, Teva Pharmaceuticals, Industries Limited, UCB S.A., Sanofi-Aventis SA, Novartis AG and Shire Plc.

Distribution Channel:
• Drug Stores
• Hospitals
• Independent Pharmacies
• Clinics

Drug Class Covered:
• Anti-Inflammatory Drugs
• Biologics
• Immunosuppressant’s
• Nonsteroidal anti-inflammatory drugs
• Corticosteroids

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Autoimmune Disease Therapeutics Market, By Distribution Channel
5.1 Introduction
5.2 Drug Stores
5.3 Hospitals
5.4 Independent Pharmacies
5.5 Clinics

6 Global Autoimmune Disease Therapeutics Market, By Drug Class
6.1 Introduction
6.2 Anti-Inflammatory Drugs
6.3 Biologics
6.4 Immunosuppressant’s
6.5 Nonsteroidal anti-inflammatory drugs
6.6 Corticosteroids

7 Global Autoimmune Disease Therapeutics Market, By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.2.6 Rest of Europe
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia Pacific
7.4 Rest of the World
7.4.1 Middle East
7.4.2 Brazil
7.4.3 Argentina
7.4.4 South Africa
7.4.5 Egypt

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 Johnson & Johnson Inc
9.2 Bayer Schering Pharma AG
9.3 Elan Corporation Plc
9.4 Abbott Laboratories
9.5 Genentech Inc
9.6 GlaxoSmithKline Plc
9.7 Bristol-Myers Squibb
9.8 Chugai Pharmaceutical Co. Ltd.
9.9 Merck & Co. Inc
9.10 Amgen Inc
9.11 Eli Lilly and Company
9.12 F. Hoffmann-La Roche AG
9.13 Biogen Idec Inc
9.14 Teva Pharmaceuticals Industries Limited
9.15 UCB S.A.
9.16 Sanofi-Aventis SA
9.17 Novartis AG
9.18 Shire Plc

List of Tables
Table 1 Global Autoimmune Disease Therapeutics Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Autoimmune Disease Therapeutics Market Outlook, By Distribution Channel (2013-2022) ($MN)
Table 3 Global Autoimmune Disease Therapeutics Market Outlook, By Drug Stores (2013-2022) ($MN)
Table 4 Global Autoimmune Disease Therapeutics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 5 Global Autoimmune Disease Therapeutics Market Outlook, By Independent Pharmacies (2013-2022) ($MN)
Table 6 Global Autoimmune Disease Therapeutics Market Outlook, By Clinics (2013-2022) ($MN)
Table 7 Global Autoimmune Disease Therapeutics Market Outlook, By Drug Class (2013-2022) ($MN)
Table 8 Global Autoimmune Disease Therapeutics Market Outlook, By Anti-Inflammatory Drugs (2013-2022) ($MN)
Table 9 Global Autoimmune Disease Therapeutics Market Outlook, By Biologics (2013-2022) ($MN)
Table 10 Global Autoimmune Disease Therapeutics Market Outlook, By Immunosuppressant’s (2013-2022) ($MN)
Table 11 Global Autoimmune Disease Therapeutics Market Outlook, By Nonsteroidal anti-inflammatory drugs (2013-2022) ($MN)
Table 12 Global Autoimmune Disease Therapeutics Market Outlook, By Corticosteroids (2013-2022) ($MN)
Table 13 North America Autoimmune Disease Therapeutics Market Outlook, By Distribution Channel (2013-2022) ($MN)
Table 14 North America Autoimmune Disease Therapeutics Market Outlook, By Drug Stores (2013-2022) ($MN)
Table 15 North America Autoimmune Disease Therapeutics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 16 North America Autoimmune Disease Therapeutics Market Outlook, By Independent Pharmacies (2013-2022) ($MN)
Table 17 North America Autoimmune Disease Therapeutics Market Outlook, By Clinics (2013-2022) ($MN)
Table 18 North America Autoimmune Disease Therapeutics Market Outlook, By Drug Class (2013-2022) ($MN)
Table 19 North America Autoimmune Disease Therapeutics Market Outlook, By Anti-Inflammatory Drugs (2013-2022) ($MN)
Table 20 North America Autoimmune Disease Therapeutics Market Outlook, By Biologics (2013-2022) ($MN)
Table 21 North America Autoimmune Disease Therapeutics Market Outlook, By Immunosuppressant’s (2013-2022) ($MN)
Table 22 North America Autoimmune Disease Therapeutics Market Outlook, By Nonsteroidal anti-inflammatory drugs (2013-2022) ($MN)
Table 23 North America Autoimmune Disease Therapeutics Market Outlook, By Corticosteroids (2013-2022) ($MN)
Table 24 Europe Autoimmune Disease Therapeutics Market Outlook, By Distribution Channel (2013-2022) ($MN)
Table 25 Europe Autoimmune Disease Therapeutics Market Outlook, By Drug Stores (2013-2022) ($MN)
Table 26 Europe Autoimmune Disease Therapeutics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 27 Europe Autoimmune Disease Therapeutics Market Outlook, By Independent Pharmacies (2013-2022) ($MN)
Table 28 Europe Autoimmune Disease Therapeutics Market Outlook, By Clinics (2013-2022) ($MN)
Table 29 Europe Autoimmune Disease Therapeutics Market Outlook, By Drug Class (2013-2022) ($MN)
Table 30 Europe Autoimmune Disease Therapeutics Market Outlook, By Anti-Inflammatory Drugs (2013-2022) ($MN)
Table 31 Europe Autoimmune Disease Therapeutics Market Outlook, By Biologics (2013-2022) ($MN)
Table 32 Europe Autoimmune Disease Therapeutics Market Outlook, By Immunosuppressant’s (2013-2022) ($MN)
Table 33 Europe Autoimmune Disease Therapeutics Market Outlook, By Nonsteroidal anti-inflammatory drugs (2013-2022) ($MN)
Table 34 Europe Autoimmune Disease Therapeutics Market Outlook, By Corticosteroids (2013-2022) ($MN)
Table 35 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Distribution Channel (2013-2022) ($MN)
Table 36 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Drug Stores (2013-2022) ($MN)
Table 37 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 38 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Independent Pharmacies (2013-2022) ($MN)
Table 39 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Clinics (2013-2022) ($MN)
Table 40 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Drug Class (2013-2022) ($MN)
Table 41 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Anti-Inflammatory Drugs (2013-2022) ($MN)
Table 42 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Biologics (2013-2022) ($MN)
Table 43 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Immunosuppressant’s (2013-2022) ($MN)
Table 44 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Nonsteroidal anti-inflammatory drugs (2013-2022) ($MN)
Table 45 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Corticosteroids (2013-2022) ($MN)
Table 46 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Distribution Channel (2013-2022) ($MN)
Table 47 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Drug Stores (2013-2022) ($MN)
Table 48 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 49 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Independent Pharmacies (2013-2022) ($MN)
Table 50 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Clinics (2013-2022) ($MN)
Table 51 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Drug Class (2013-2022) ($MN)
Table 52 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Anti-Inflammatory Drugs (2013-2022) ($MN)
Table 53 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Biologics (2013-2022) ($MN)
Table 54 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Immunosuppressant’s (2013-2022) ($MN)
Table 55 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Nonsteroidal anti-inflammatory drugs (2013-2022) ($MN)
Table 56 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Corticosteroids (2013-2022) ($MN)



【レポートのキーワード】

自己免疫疾患薬、自己免疫疾患治療、薬局、病院、抗炎症剤、生物製剤

★調査レポート[自己免疫疾患治療薬の世界市場]販売に関する免責事項
★調査レポート[自己免疫疾患治療薬の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆